Vicor Technologies’ PD2i(R) Nonlinear Algorithm Selected for Use in Screening Initiative to Identify Youth at Risk of Sudden Cardiac Death
BOCA RATON, FL–(Marketwire – December 10, 2009) – David H. Fater, CEO of Vicor Technologies,
Inc. (OTCBB: VCRT), today announced that its PD2i® nonlinear algorithm
has been selected by Dr. Sanjay Sharma to be used in a month-long cardiac
screening initiative to be held in South East London in April 2010. Vicor
Technologies is a biotechnology company focused on the commercialization of
innovative, non-invasive medical devices and diagnostics using its
patented, proprietary PD2i® nonlinear algorithm and software to stratify
patients at risk of sudden cardiac death or autonomic dysfunction, and
trauma victims in need of lifesaving intervention.